The new medicare drug benefit: Formularies and their potential effects on access to medications
- 1 July 2005
- journal article
- Published by Springer Science and Business Media LLC in Journal of General Internal Medicine
- Vol. 20 (7), 662-665
- https://doi.org/10.1007/s11606-005-0115-3
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Barriers to patient-physician communication about out-of-pocket costsJournal of General Internal Medicine, 2004
- Pharmacy Benefits and the Use of Drugs by the Chronically IllJAMA, 2004
- Provider Perceptions of Pharmacy ManagementMedical Care, 2004
- Physicians’ Views Of Formularies: Implications For Medicare Drug Benefit DesignHealth Affairs, 2004
- The Effect of Incentive-Based Formularies on Prescription-Drug Utilization and SpendingThe New England Journal of Medicine, 2003
- Clinical and economic consequences of reference pricing for dihydropyridine calcium channel blockersClinical Pharmacology & Therapeutics, 2003
- Adverse Selection and the Challenges to Stand-Alone Prescription Drug InsurancePublished by National Bureau of Economic Research ,2003
- Outcomes of Reference Pricing for Angiotensin-Converting–Enzyme InhibitorsThe New England Journal of Medicine, 2002
- Treating patients with documented atherosclerosis to national cholesterol education program-recommended low-density-lipoprotein cholesterol goals with atorvastatin, fluvastatin, lovastatin and simvastatinJournal of the American College of Cardiology, 1998